Mark Trusheim

Mark Trusheim

Company: Tufts Medical Center

Job title: Strategic Director


Mark co-leads the NEWDIGS PIVOT (Payment Innovation for Value and Outcomes for Therapeutics) consortium to improve appropriate patient access in ways that work for all stakeholders.  He draws on over 25 years of experience from drug development through policy to payer coverage and reimbursement.


Panel Discussion: Gene Therapy Health Plan Coverage & Reimbursement Challenges for Private Payers 10:00 am

Understanding payer concerns around gene therapy coverage: why are some therapies deemed too high-risk to cover? Comparing current methods payers are introducing to help make value-based contracts work Exploring novel financing options to ensure these high-cost speciality drugs can be made accessible to those in needRead more

day: Day Two AM

Highlighting the Many Innovative Payment Tools to Enable Market Access 9:00 am

Exploring the wide of variety of new payment models available  Considerations for selecting a model for your unique condition and therapeutic Planning to overcome the legal and implementation barriersRead more

day: Day Two AM

Chair’s Opening Remarks 7:50 am

Read more

day: Day One AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.